Search Results - "Schmeling, David O. "

Refine Results
  1. 1

    Age-Specific Prevalence of Epstein-Barr Virus Infection Among Individuals Aged 6-19 Years in the United States and Factors Affecting Its Acquisition by Balfour, Henry H., Sifakis, Frangiscos, Sliman, Joseph A., Knight, Jennifer A., Schmeling, David O., Thomas, William

    Published in The Journal of infectious diseases (15-10-2013)
    “…Background. Data on the age-specific prevalence of Epstein-Barr virus (EBV) infection are relevant for determining when to administer a prophylactic vaccine…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events by Dunmire, Samantha K, Grimm, Jennifer M, Schmeling, David O, Balfour, Jr, Henry H, Hogquist, Kristin A

    Published in PLoS pathogens (01-12-2015)
    “…Epstein-Barr virus (EBV) is a human herpesvirus that causes acute infectious mononucleosis and is associated with cancer and autoimmune disease. While many…”
    Get full text
    Journal Article
  4. 4

    Primary EBV infection induces an expression profile distinct from other viruses but similar to hemophagocytic syndromes by Dunmire, Samantha K, Odumade, Oludare A, Porter, Jean L, Reyes-Genere, Juan, Schmeling, David O, Bilgic, Hatice, Fan, Danhua, Baechler, Emily C, Balfour, Jr, Henry H, Hogquist, Kristin A

    Published in PloS one (17-01-2014)
    “…Epstein-Barr Virus (EBV) causes infectious mononucleosis and establishes lifelong infection associated with cancer and autoimmune disease. To better understand…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus by Hendricks, Deborah W, Balfour, Jr, Henry H, Dunmire, Samantha K, Schmeling, David O, Hogquist, Kristin A, Lanier, Lewis L

    Published in The Journal of immunology (1950) (15-05-2014)
    “…CMV induces the expansion of a unique subset of human NK cells expressing high levels of the activating CD94-NKG2C receptor that persist after control of the…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The promise of a prophylactic Epstein–Barr virus vaccine by Balfour , Henry H., Schmeling, David O., Grimm-Geris, Jennifer M.

    Published in Pediatric research (01-01-2020)
    “…The worldwide burden of disease due to Epstein–Barr virus (EBV) infection is enormous. Diseases include endemic Burkitt lymphoma, infectious mononucleosis,…”
    Get full text
    Journal Article
  9. 9

    A virologic pilot study of valacyclovir in infectious mononucleosis by Balfour, Henry H, Hokanson, Kristin M, Schacherer, Robyn M, Fietzer, Christine M, Schmeling, David O, Holman, Carol J, Vezina, Heather E, Brundage, Richard C

    Published in Journal of clinical virology (01-05-2007)
    “…Abstract Background Infectious mononucleosis decreases the productivity of many college students and Epstein–Barr virus (EBV) infection may result in long-term…”
    Get full text
    Journal Article
  10. 10

    Rapid antibody responses to Epstein-Barr virus correlate with reduced severity of primary infection by Geris, Jennifer M., Stancari, Arianna L., Meirhaeghe, Madeline R., Gautam, Sakhi, Cayatte, Corinne, Schmeling, David O., Okour, Malek F., Brundage, Richard C., Hayes, Gregory M., Balfour, Henry H.

    Published in Journal of clinical virology (01-10-2022)
    “…•More rapid antibody responses in college freshmen who contracted a primary EBV infection.•during prospective surveillance correlated with a lower severity of…”
    Get full text
    Journal Article
  11. 11

    The Impact of Donor Viral Replication at Transplant on Recipient Infections Posttransplant: A Prospective Study by Verghese, Priya S, Schmeling, David O, Knight, Jennifer A, Matas, Arthur J, Balfour, Henry H

    Published in Transplantation (01-03-2015)
    “…BACKGROUNDOrgan donors are often implicated as the source of posttransplant recipient infection. We prospectively studied kidney and liver donor-recipient…”
    Get full text
    Journal Article
  12. 12

    Primary Epstein-Barr virus infection does not erode preexisting CD8⁺ T cell memory in humans by Odumade, Oludare A, Knight, Jennifer A, Schmeling, David O, Masopust, David, Balfour, Jr, Henry H, Hogquist, Kristin A

    Published in The Journal of experimental medicine (12-03-2012)
    “…Acute Epstein-Barr virus (EBV) infection results in an unusually robust CD8(+) T cell response in young adults. Based on mouse studies, such a response would…”
    Get full text
    Journal Article
  13. 13

    Epstein-Barr Virus DNA in Parental Oral Secretions: A Potential Source of Infection for Their Young Children by Cederberg, Laurel E, Rabinovitch, Mark D, Grimm-Geris, Jennifer M, Schmeling, David O, Filtz, Emma A, Condon, Lawrence M, Balfour, Henry H

    Published in Clinical infectious diseases (07-01-2019)
    “…Epstein-Barr virus (EBV) DNA in parental oral secretions is a potential source of primary infection for children: 28% of parents were positive and prevalence…”
    Get full text
    Journal Article
  14. 14

    Age-Specific Prevalence of Epstein-Barr Virus Infection Among Minnesota Children: Effects of Race/Ethnicity and Family Environment by Condon, Lawrence M., Cederberg, Laurel E., Rabinovitch, Mark D., Liebo, Rhoda V., Go, Janice C., Delaney, Amanda S., Schmeling, David O., Thomas, William, Balfour, Henry H.

    Published in Clinical infectious diseases (15-08-2014)
    “…Background. Primary Epstein-Barr virus (EBV) infection affects the host differently according to when in life it is acquired. Understanding risk factors for…”
    Get full text
    Journal Article
  15. 15

    Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV by Bu, Wei, Hayes, Gregory M, Liu, Hui, Gemmell, Lorraine, Schmeling, David O, Radecki, Pierce, Aguilar, Fiona, Burbelo, Peter D, Woo, Jennifer, Balfour, Jr, Henry H, Cohen, Jeffrey I

    Published in Clinical and vaccine immunology (01-04-2016)
    “…Prospective studies of antibodies to multiple Epstein-Barr virus (EBV) proteins and EBV neutralizing antibodies in the same individuals before, during, and…”
    Get full text
    Journal Article
  16. 16

    Valganciclovir Administration to Kidney Donors to Reduce the Burden of Cytomegalovirus and Epstein-Barr Virus Transmission During Transplantation by Verghese, Priya S, Schmeling, David O, Knight, Jennifer A, Matas, Arthur J, Balfour, Henry H

    Published in Transplantation (01-06-2015)
    “…BACKGROUNDCytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections are a significant cause of morbidity and mortality in transplant recipients and are…”
    Get full text
    Journal Article
  17. 17

    Transplantation of solid organ recipients shedding Epstein‐Barr virus DNA pre‐transplant: A prospective study by Verghese, Priya S., Schmeling, David O., Filtz, Emma A., Grimm, Jennifer M., Matas, Arthur J., Balfour, Henry H.

    Published in Clinical transplantation (01-11-2017)
    “…Epstein‐Barr virus (EBV) poses a significant threat to patient and graft survival post‐transplant. We hypothesized that recipients who shed EBV at transplant…”
    Get full text
    Journal Article
  18. 18

    Prospective studies of infectious mononucleosis in university students by Grimm, Jennifer M, Schmeling, David O, Dunmire, Samantha K, Knight, Jennifer A, Mullan, Beth D, Ed, Julie A, Brundage, Richard C, Hogquist, Kristin A, Balfour, Henry H

    Published in Clinical & translational immunology (01-08-2016)
    “…We performed an intensive prospective study designed to obtain as much data as possible on the incubation and early illness periods of primary Epstein–Barr…”
    Get full text
    Journal Article
  19. 19

    Epstein–Barr virus dynamics in asymptomatic immunocompetent adults: an intensive 6‐month study by Johnson, Kristin H, Webb, Chiu‐Ho, Schmeling, David O, Brundage, Richard C, Balfour, Henry H

    Published in Clinical & translational immunology (13-05-2016)
    “…Characterizing Epstein–Barr virus (EBV) dynamics in asymptomatic immunocompetent persons provides a baseline for defining quantitative thresholds associated…”
    Get full text
    Journal Article
  20. 20

    The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events: e1005286 by Dunmire, Samantha K, Grimm, Jennifer M, Schmeling, David O, Jr, Henry HBalfour, Hogquist, Kristin A

    Published in PLoS pathogens (01-12-2015)
    “…Epstein-Barr virus (EBV) is a human herpesvirus that causes acute infectious mononucleosis and is associated with cancer and autoimmune disease. While many…”
    Get full text
    Journal Article